Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma
Condition(s):Metastatic Nasopharyngeal Carcinoma; Intermittent Systematic ChemotherapyLast Updated:March 26, 2024Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Metastatic Nasopharyngeal Carcinoma; Intermittent Systematic ChemotherapyLast Updated:March 26, 2024Not yet recruiting
Condition(s):Metastatic Nasopharyngeal CarcinomaLast Updated:August 2, 2022Not yet recruiting
Condition(s):Recurrent or Metastatic Nasopharyngeal CarcinomaLast Updated:April 26, 2023Recruiting
Condition(s):Recurrent Metastatic Nasopharyngeal CarcinomaLast Updated:February 8, 2023Not yet recruiting
Condition(s):Recurrent or Metastatic Nasopharyngeal CarcinomaLast Updated:February 5, 2024Recruiting
Condition(s):Metastatic Nasopharyngeal Carcinoma; Recurrent Nasopharyngeal CarcinomaLast Updated:November 13, 2020Recruiting
Condition(s):Nasopharyngeal Carcinoma; Immune Checkpoint InhibitorsLast Updated:June 12, 2023Not yet recruiting
Condition(s):Metastatic Nasopharyngeal CancerLast Updated:February 5, 2024Recruiting
Condition(s):Nasopharyngeal CarcinomaLast Updated:March 7, 2024Recruiting
Condition(s):Nasopharyngeal CarcinomaLast Updated:June 8, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.